December 27, 2022
Akira Sakurai, Senior Scientist for Biopharmaceutical Quality (left) and Futaba Honda, Director, Office of Cellular and Tissue-based Products, PMDA There have been calls from the pharma industry for Japan to ease regulations around the Cartagena Act, contending that the law...read more